Discontinued — last reported Q4 '25
Blackstone Interest Paid increased by 12.1% to $113.67M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 17.3%, from $137.53M to $113.67M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 24.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.16M | $51.64M | $40.00M | $75.18M | $48.73M | $97.24M | $40.73M | $99.10M | $117.72M | $75.71M | $107.81M | $76.49M | $95.26M | $98.06M | $137.53M | $96.06M | $152.38M | $101.43M | $113.67M |
| QoQ Change | — | +0.9% | -22.5% | +87.9% | -35.2% | +99.5% | -58.1% | +143.3% | +18.8% | -35.7% | +42.4% | -29.1% | +24.5% | +2.9% | +40.2% | -30.2% | +58.6% | -33.4% | +12.1% |
| YoY Change | — | — | — | — | -4.7% | +88.3% | +1.8% | +31.8% | +141.6% | -22.1% | +164.7% | -22.8% | -19.1% | +29.5% | +27.6% | +25.6% | +60.0% | +3.4% | -17.3% |